GLQ-30124-93645
4 vaccinations
2 coded responses
48 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 840 / UT
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
9TN-24853-08685
Child or adolescent in my care · Female · 2022-07-01
K5N-29943-04731
Child or adolescent in my care · Male · 2022-11-02
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Moderna
- 2020-12-22
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-05
- 2021-01-12
-
2021-01-18
Dose 2 — Moderna
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-04-19
- 2021-07-19
-
2021-10-29
Dose 3 — Moderna
- 2021-10-29
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Vomiting · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2022-01-28
- 2022-04-29
-
2022-09-28
Dose 4 — Pfizer-BioNTech
- 2022-09-28
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-30
- 2022-10-02
- 2022-10-04
- 2022-10-05
- 2022-10-12
- 2022-10-19
-
2022-10-26
Survey response — day 28, dose 4MedDRA: Upper respiratory tract infection — Feeling: GoodFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-02
-
2022-11-09
Survey response — day 42, dose 4MedDRA: SARS-CoV-2 test negative, Viral infection — Feeling: GoodFree text: Virus 2 weeks ago. Negative covid. Resolving.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-28
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Moderna | |
| 2 | 2021-01-18 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-09-28 | Pfizer-BioNTech | No |
Free text
Release 12 — day 28, dose 4
Symptoms: Upper respiratory infection
Release 12 — day 42, dose 4
Symptoms: Virus 2 weeks ago. Negative covid. Resolving.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release